Evidence map›Paper›PMID 28108540›Full record

ArticleDiabetes care2017

Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.

William T Cefalu, John B Buse, Jaakko Tuomilehto, G Alexander Fleming, Ele Ferrannini, Hertzel C Gerstein, Peter H Bennett, Ambady Ramachandran, Itamar Raz, Julio Rosenstock and 1 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

William T CefaluPennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA william.cefalu@pbrc.edu.
John B BuseUniversity of North Carolina School of Medicine, Chapel Hill, NC.
Jaakko TuomilehtoChronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
G Alexander FlemingKinexum, Harper's Ferry, WV.
Ele FerranniniCNR Institute of Clinical Physiology, Pisa, Italy.
Hertzel C GersteinMcMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Peter H BennettNational Institutes of Health, Phoenix, AZ.
Ambady RamachandranIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Itamar RazDiabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.
Julio RosenstockDallas Diabetes Research Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0001-8324-3275
Steven E KahnVA Puget Sound Health Care System and University of Washington, Seattle, WA.

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RASKIN, ILYA · 2005 to 2019
$24.9M
NCCIH NIH HHS P50 AT002776NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2HyperglycemiaHumans

Identifiers

PMID28108540
PMCPMC5864140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.